🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +40.14% on $5214.T in just 0m.
KAL
$KALA
🔒 US EquitiesKala Bio Inc
AVG HISTORICAL GAP
+0.11%
MAX GAP RECORD
+5.01%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $KALA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$KALA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 17, 2026 Earnings Release 2026-11-17 (AFTER CLOSE) | 🔮 UPCOMING 🔒 |
| Nov 19, 2025 Earnings Release 2025-11-19 (BEFORE OPEN) |
+0.15%
|
| Aug 08, 2025 Earnings Release 2025-08-08 (BEFORE OPEN) |
-0.56%
|
| May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE) |
-0.31%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-0.99%
|
| Aug 06, 2024 Earnings Release 2024-08-06 (AFTER CLOSE) |
-1.29%
|
| May 14, 2024 Earnings Release 2024-05-14 (AFTER CLOSE) |
-2.26%
|
| Mar 28, 2024 Earnings Release 2024-03-28 (BEFORE OPEN) |
-0.25%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.4%
Bullish Gaps (3)
Bearish Gaps (3)
Neutral / Flat (5)
📖 Intelligence Summary
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗